Table 2.
Performance for predicting progression to severe illness with logistic regression analysis
Day 0 | P | Day 4 | P | Changes from Day 0 to Day 4 | P | |
---|---|---|---|---|---|---|
APACHE-II | 0.78(0.69~0.88) | 0.554 | 0.77(0.66~0.89) | 0.076 | 0.82(0.72~0.91) | 0.046 |
NLR | 0.78(0.67~0.88) | 0.636 | 0.84(0.75~0.93) | 0.156 | 0.78(0.67~0.88) | 0.001 |
D-dimer | 0.75(0.64~0.85) | 0.410 | 0.78(0.67~0.88) | 0.007 | 0.78(0.67~0.88) | 0.001 |
PGV | 0.76(0.65~0.86) | 0.753 | 0.83(0.73~0.93) | 0.015 | 0.84(0.74~0.93) | 0.015 |
PSV | 0.76(0.65~0.86) | 0.644 | 0.87(0.77~0.97) | 0.256 | 0.92(0.86~0.99) | 0.464 |
PCV | 0.76(0.66~0.86) | 0.738 | 0.88(0.79~0.97) | 0.572 | 0.91(0.85~0.98) | 0.190 |
CT features | 0.76(0.66~0.86) | Reference | 0.89(0.80~0.97) | Reference | 0.93(0.87~0.99) | Reference |
NLR + CT features | 0.78(0.67~0.88) | 0.551 | 0.89(0.80~0.97) | 0.432 | 0.93(0.87~0.99) | 0.336 |
Note:
(a) Results are presented as the area under the receiver operating characteristic curve (AUC) along with 95% CI.
(b) PGV=Percentage of GGO volume; PSV=Percentage of semi-consolidation volume; PCV=Percentage of consolidation volume.
(c) All models were adjusted for traditional clinical variables including age and gender.